Thomas H. Kean, Representative
buy disclosed on 18 Jun 2026 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Be careful chasing
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Public company research profile
This public-disclosure research profile is not investment advice. It summarizes historical public filings, source links, confidence context, and hypothetical outcomes so readers can verify the evidence themselves.
Company research history
Source-transparent disclosure history for this company, built from public CopyWindow signals and previous hypothetical outcomes.
Thomas H. Kean, Representative
buy disclosed on 18 Jun 2026 via House STOCK Act disclosures
Thomas H. Kean, Representative
buy disclosed on 13 Apr 2026 via House STOCK Act disclosures
Gilbert Cisneros, Representative
sell disclosed on 12 Jan 2026 via House STOCK Act disclosures
Gilbert Cisneros, Representative
buy disclosed on 15 Dec 2025 via House STOCK Act disclosures
Thomas H. Kean, Representative
buy disclosed on 18 Sept 2025 via House STOCK Act disclosures
Rob Bresnahan, Representative
buy disclosed on 31 May 2025 via House STOCK Act disclosures
Rob Bresnahan, Representative
sell disclosed on 28 Apr 2025 via House STOCK Act disclosures
Daniel Goldman, Representative
sell disclosed on 13 Aug 2023 via House STOCK Act disclosures
Kathy Manning, Representative
sell disclosed on 14 Sept 2022 via House STOCK Act disclosures
Kathy Manning, Representative
buy disclosed on 10 Aug 2022 via House STOCK Act disclosures